These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17276991)

  • 1. Ubiquitin-interacting motifs inhibit aggregation of polyQ-expanded huntingtin.
    Miller SLH; Scappini EL; O'Bryan J
    J Biol Chem; 2007 Mar; 282(13):10096-10103. PubMed ID: 17276991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.
    Tower C; Fu L; Gill R; Prichard M; Lesort M; Sztul E
    Neurobiol Dis; 2011 Jan; 41(1):11-22. PubMed ID: 20732421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.
    Li X; Wang CE; Huang S; Xu X; Li XJ; Li H; Li S
    Hum Mol Genet; 2010 Jun; 19(12):2445-55. PubMed ID: 20354076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of the ubiquitin binding protein Tollip against the toxicity of polyglutamine-expansion proteins.
    Oguro A; Kubota H; Shimizu M; Ishiura S; Atomi Y
    Neurosci Lett; 2011 Oct; 503(3):234-9. PubMed ID: 21896309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein.
    Jiang H; Nucifora FC; Ross CA; DeFranco DB
    Hum Mol Genet; 2003 Jan; 12(1):1-12. PubMed ID: 12490527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
    Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
    Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation.
    Zucchelli S; Marcuzzi F; Codrich M; Agostoni E; Vilotti S; Biagioli M; Pinto M; Carnemolla A; Santoro C; Gustincich S; Persichetti F
    J Biol Chem; 2011 Jul; 286(28):25108-17. PubMed ID: 21454471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction with polyglutamine-expanded huntingtin alters cellular distribution and RNA processing of huntingtin yeast two-hybrid protein A (HYPA).
    Jiang YJ; Che MX; Yuan JQ; Xie YY; Yan XZ; Hu HY
    J Biol Chem; 2011 Jul; 286(28):25236-45. PubMed ID: 21566141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. scyllo-Inositol promotes robust mutant Huntingtin protein degradation.
    Lai AY; Lan CP; Hasan S; Brown ME; McLaurin J
    J Biol Chem; 2014 Feb; 289(6):3666-76. PubMed ID: 24352657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.
    Muchowski PJ; Schaffar G; Sittler A; Wanker EE; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7841-6. PubMed ID: 10859365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes.
    Juenemann K; Schipper-Krom S; Wiemhoefer A; Kloss A; Sanz Sanz A; Reits EAJ
    J Biol Chem; 2013 Sep; 288(38):27068-27084. PubMed ID: 23908352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Rho kinases enhances the degradation of mutant huntingtin.
    Bauer PO; Wong HK; Oyama F; Goswami A; Okuno M; Kino Y; Miyazaki H; Nukina N
    J Biol Chem; 2009 May; 284(19):13153-64. PubMed ID: 19278999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3.
    Berke SJ; Chai Y; Marrs GL; Wen H; Paulson HL
    J Biol Chem; 2005 Sep; 280(36):32026-34. PubMed ID: 16040601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein.
    Bauer PO; Goswami A; Wong HK; Okuno M; Kurosawa M; Yamada M; Miyazaki H; Matsumoto G; Kino Y; Nagai Y; Nukina N
    Nat Biotechnol; 2010 Mar; 28(3):256-63. PubMed ID: 20190739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
    Preisinger E; Jordan BM; Kazantsev A; Housman D
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).
    Prigge JR; Schmidt EE
    BMC Mol Biol; 2007 Sep; 8():76. PubMed ID: 17868456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.
    Poirier MA; Jiang H; Ross CA
    Hum Mol Genet; 2005 Mar; 14(6):765-74. PubMed ID: 15689354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin.
    Yang H; Zhong X; Ballar P; Luo S; Shen Y; Rubinsztein DC; Monteiro MJ; Fang S
    Exp Cell Res; 2007 Feb; 313(3):538-50. PubMed ID: 17141218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.